As AI vendor ROI claims grow bolder, health systems require more proof

As bold claims about the return on investment (ROI) from AI vendors become more frequent, healthcare systems like Mass General Brigham are demanding more evidence to back up these promises. Rebecca Mishuris, chief health information officer, insists on a thorough assessment questionnaire for any AI vendor before proceeding with procurement discussions. This heightened scrutiny reflects a broader trend where healthcare institutions are increasingly skeptical of AI solutions, seeking substantial proof to ensure they're making sound investments. This shift underscores the growing importance of data-driven validation in the rapidly evolving AI healthcare market.